IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
115 hedge funds and large institutions have $495M invested in IVERIC bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 16 closing their positions.
134% more call options, than puts
Call options by funds: $5.48M | Put options by funds: $2.34M
55% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 29
4% less funds holding
Funds holding: 120 → 115 (-5)
9% less capital invested
Capital invested by funds: $542M → $495M (-$46.5M)
31% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 16
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yiheng Capital Management
San Francisco,
California
|
+$15.9M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$10.8M |
| 3 |
LGM
Logos Global Management
San Francisco,
California
|
+$7.28M |
| 4 |
CC
Commodore Capital
New York
|
+$2.76M |
| 5 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.23M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Consonance Capital Management
New York
|
-$16.4M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$10.6M |
| 3 |
BCM
Burrage Capital Management
Boston,
Massachusetts
|
-$9.59M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$5.21M |
| 5 |
Goldman Sachs
New York
|
-$4.31M |
ISEE Hedge Fund Activity: Q1 2021 in Review
115 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q1 2021, worth a combined $495M — down 8.6% from $542M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of ISEE and 11 opened new positions — a net loss of 5 holders — while 29 trimmed existing stakes and 45 added.
The largest buyer was Yiheng Capital Management, adding an estimated $15.9M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $16.4M sold.
- 115 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q1 2021, down from 120 in Q4 2020.
- Funds reported $495M of IVERIC bio, Inc. Common Stock stock for Q1 2021, down 8.6% quarter-over-quarter.
- 11 funds opened new IVERIC bio, Inc. Common Stock positions in Q1 2021 and 16 closed out, a net change of -5 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q1 2021 was Yiheng Capital Management, an estimated $15.9M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q1 2021 was Consonance Capital Management, an estimated $16.4M sold.
Based on aggregated 13F filings for Q1 2021.